Consolidated statements of changes in equity - USD ($)
$ in Millions
Total
Equity attributable to owners of parent [member]
Share capital
Treasury shares
Retained earnings
Total value adjustments
Non-controlling interests [member]
Equity | Previously stated [member] $ 78,692 $ 78,614 $ 944 $ (69) $ 82,191 $ (4,452) $ 78
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member] 3 3     3    
Equity | Restated Value Adjustments [member] 78,695 78,617 944 (69) 82,194 (4,452) 78
Equity | Previously stated [member] 78,692 78,614 944 (69) 82,191 (4,452) 78
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member] 3 3     3    
Equity | Restated Value Adjustments [member] 78,695 78,617 944 (69) 82,194 (4,452) 78
Equity 51,504 51,426 936 (67) 55,645 (5,088) 78
Equity at beginning of period (Previously stated [member]) at Dec. 31, 2018 78,692 78,614 944 (69) 82,191 (4,452) 78
Equity at beginning of period (Increase (decrease) due to changes in accounting policy required by IFRSs [member]) at Dec. 31, 2018 3 3     3    
Equity at beginning of period (Restated Value Adjustments [member]) at Dec. 31, 2018 78,695 78,617 944 (69) 82,194 (4,452) 78
Net income 8,567 8,565     8,565   2
Other comprehensive income (667) (667)     (54) (613)  
Total comprehensive income 7,900 7,898     8,511 (613) 2
Dividends (6,645) (6,645)     (6,645)    
Dividend in kind (23,434) (23,434)     (23,434)    
Purchase of treasury shares (2,972) (2,972)   (17) (2,955)    
Reduction of share capital     (8) 12 (4)    
Exercise of options and employee transactions, equity impact 200 200   3 197    
Equity-based compensation 447 447   4 443    
Shares delivered to divested business employees, equity impact 32 32     32    
Taxes on treasury shares (185) (185)     (185)    
Increase of treasury share repurchase obligation under a share buyback trading plan (2,289) (2,289)     (2,289)    
Transaction costs recorded in equity (253) (253)     (253)    
Fair value adjustments on financial assets sold         19 (19)  
Fair value adjustments related to divestments         4 (4)  
Impact of change in ownership of consolidated entities (5) (3)     (3)   (2)
Other movements 13 13     13    
Total of other equity movements (35,091) (35,089) (8) 2 (35,060) (23) (2)
Equity at end of period at Jun. 30, 2019 51,504 51,426 936 (67) 55,645 (5,088) 78
Tax reform impact on deferred tax on treasury shares 69            
Equity 47,307 47,229 944 (63) 51,518 (5,170) 78
Equity 51,504 51,426 936 (67) 55,645 (5,088) 78
Equity at beginning of period at Mar. 31, 2019 47,307 47,229 944 (63) 51,518 (5,170) 78
Net income 6,800 6,799     6,799   1
Other comprehensive income 90 89       89 1
Total comprehensive income 6,890 6,888     6,799 89 2
Dividend in kind 2,927 2,927     2,927    
Purchase of treasury shares (2,770) (2,770)   (16) (2,754)    
Reduction of share capital     (8) 12 (4)    
Equity-based compensation 175 175     175    
Shares delivered to divested business employees, equity impact 32 32     32    
Taxes on treasury shares [1] (185) (185)     (185)    
Increase of treasury share repurchase obligation under a share buyback trading plan (2,573) (2,573)     (2,573)    
Transaction costs recorded in equity [2] (301) (301)     (301)    
Fair value adjustments on financial assets sold         3 (3)  
Fair value adjustments related to divestments         4 (4)  
Impact of change in ownership of consolidated entities (5) (3)     (3)   (2)
Other movements 7 7     7    
Total of other equity movements (2,693) (2,691) (8) (4) (2,672) (7) (2)
Equity at end of period at Jun. 30, 2019 51,504 51,426 936 (67) 55,645 (5,088) 78
Tax reform impact on deferred tax on treasury shares 69            
Equity 51,504 51,426 936 (67) 55,645 (5,088) 78
Equity 55,551 55,474 936 (80) 59,275 (4,657) 77
Equity 53,885 55,474 936 (80) 59,275 (4,657) 77
Equity at beginning of period at Dec. 31, 2019 55,551 55,474 936 (80) 59,275 (4,657) 77
Net income 4,040 4,043     4,043   (3)
Other comprehensive income 175 176     (12) 188 (1)
Total comprehensive income 4,215 4,219     4,031 188 (4)
Dividends (6,987) (6,987)     (6,987)    
Purchase of treasury shares (150) (150)   (1) (149)    
Reduction of share capital     (23) 31 (8)    
Exercise of options and employee transactions, equity impact 823 823   8 815    
Equity-based compensation 365 365   5 360    
Shares delivered to divested business employees, equity impact 29 29   0 29    
Taxes on treasury shares 30 30     30    
Fair value adjustments on financial assets sold         90 (90)  
Other movements 9 9     9    
Total of other equity movements (5,881) (5,881) (23) 43 (5,811) (90)  
Equity at end of period at Jun. 30, 2020 53,885 53,812 913 (37) 57,495 (4,559) 73
Equity 50,977 50,903 936 (68) 55,356 (5,321) 74
Equity 53,885 53,812 913 (37) 57,495 (4,559) 73
Equity at beginning of period at Mar. 31, 2020 50,977 50,903 936 (68) 55,356 (5,321) 74
Net income 1,867 1,867     1,867   0
Other comprehensive income 835 836       836 (1)
Total comprehensive income 2,702 2,703     1,867 836 (1)
Purchase of treasury shares (9) (9)   0 (9)    
Reduction of share capital     (23) 31 (8)    
Equity-based compensation 203 203   0 203    
Shares delivered to divested business employees, equity impact 8 8   0 8    
Fair value adjustments on financial assets sold         74 (74)  
Other movements 4 4     4    
Total of other equity movements 206 206 (23) 31 272 (74)  
Equity at end of period at Jun. 30, 2020 53,885 53,812 913 (37) 57,495 (4,559) 73
Equity $ 53,885 $ 53,812 $ 913 $ (37) $ 57,495 $ (4,559) $ 73
[1] Included in Q2 2019 is a USD 69 million impact related to the revaluation of deferred tax liability on treasury shares that are recognized through retained earnings. This revaluation resulted from the Swiss Federal tax reform enacted in May 2019, effective January 1, 2020.
[2] Transaction costs directly attributable to the distribution (spin-off) of the Alcon business to Novartis AG shareholders.